Asklepios BioPharmaceutical
Victor Stukat Gren is an experienced professional currently serving as Head of Strategy at AskBio Inc. since June 2021, having previously held the roles of Vice President, Chief of Staff, and Senior Director of Financial Planning, Analysis & Treasury. Prior to joining AskBio, Victor spent nearly a decade at Bayer Pharmaceuticals from January 2012 to June 2021, where responsibilities included Head of Portfolio & Strategy Office, Senior Director R&D, Deputy Head Strategic Controlling, Strategic Controller, and Lead Financial Analyst. Earlier in Victor's career, finance and controlling roles were undertaken at Medrad from June 2007 to December 2011. Victor holds a Master of Business Administration (M.B.A.) from Carnegie Mellon University - Tepper School of Business and a Bachelor of Science (B.S.) from Saint Francis University.
This person is not in any teams
This person is not in any offices
Asklepios BioPharmaceutical
1 followers
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.